Research platform

Algebra Benefit-Risk Methodology Coding Platform

Invited specialists independently and blindly code FDA De Novo Decision Summaries into Risk Algebra matrices. The platform applies the validated Algebra Benefit-Risk Methodology and reports study-level evaluation metrics as a retrospective concordance evaluation.

Registration is by admin invitation only.